1

2
Jeffrey L Romine, Scott W Martin, Piyasena Hewawasam, Nicholas A Meanwell, Valentin K Gribkoff, John E Starrett Jr: Diphenyl oxadiazolones as potassium channel modulators. Bristol Myers Squibb Company, Aldo A Algieri, February 9, 1999: US05869509 (34 worldwide citation)

Novel compounds of Formula 1 are useful to treat disorders responsive to openers of the large conductance calcium-activated potassium channels: ##STR1## wherein "Het" is one of a select group of heterocyclic moieties; Z is independently for each occurrence selected from O or S; R.sup.a, R.sup.b and ...


3
Alain Martel, Jacques Banville, Alejandro A Aruffo: Sulfated .alpha.-glycolipid derivatives as cell adhesion inhibitors. Bristol Myers Squibb Company, Aldo A Algieri, September 2, 1997: US05663151 (29 worldwide citation)

There is provided novel sulfated .alpha.-glycolipid compounds of the formula ##STR1## wherein R is an acyl residue of a fatty acid;


4
Piyasena Hewawasam, Nicholas A Meanwell, Valentin K Gribkoff: 3-substituted oxindole derivatives as potassium channel modulators. Bristol Myers Squibb Company, Aldo A Algieri, October 15, 1996: US05565483 (27 worldwide citation)

There is provided novel substituted 3-phenyl oxindole derivatives of the formula ##STR1## wherein R is hydrogen, hydroxy or fluoro; R.sup.1, R.sup.2, R.sup.3


5

6
Alain Martel, John J Wright: Dicarboxymethylated glycolipid derivatives as cell adhesion inhibitors. Bristol Myers Squibb Company, Aldo A Algieri, November 11, 1997: US05686426 (22 worldwide citation)

There is provided a novel series of O-carboxymethylated .alpha.- and .beta.-glycolipid compounds of the formula ##STR1## wherein R is an acyl residue of a fatty acid;


7
Jeffrey L Romine, Scott W Martin, Piyasena Hewawasam, Nicholas A Meanwell, Valentin K Gribkoff, John E Starrett Jr: Diphenyl imidazoles as potassium channel modulators. Bristol Myers Squibb Company, Aldo A Algieri, August 7, 2001: US06271249 (21 worldwide citation)

Novel compounds of Formula 1 are useful to treat disorders responsive to openers of the large conductance calcium-activated potassium channels:


8
Michael F Parker, Katharin E McElhone, Robert A Mate, Joanne J Bronson, Yonghua Gai, Carl P Bergstrom, Lawrence R Marcin, John E Macor: α-(N-sulfonamido)acetamide derivatives as β-amyloid inhibitors. Bristol Myers Squibb Company, Aldo A Algieri, November 27, 2007: US07300936 (21 worldwide citation)

There is provided a series of novel α-(N-sulfonamido)acetamide compounds of the Formula (I) wherein R, R1, R2 and R3 are defined herein, which are inhibitors of β-amyloid peptide (β-AP) production and are useful in the treatment of Alzheimer's Disease and other conditions affected by anti-amyloid ac ...


9
Abraham Weber, Daniel Bouzard, Munir Essiz, Pierre Di Cesare, Jean Pierre Jacquet, Philippe Remuzon: 1-tertiary-alkyl-substituted naphthyridine carboxylic acid antibacterial agents. Bristol Myers Company, Robert E Carnahan, Aldo A Algieri, September 4, 1990: US04954507 (20 worldwide citation)

There are disclosed new naphthyridine- and quinoline-carboxylic acids having a 1-tertiary-alkyl substituent, compositions containing them, and their use in treating bacterial infections in warm-blooded animals. Also disclosed are novel amines and intermediates used in the preparation of the naphthyr ...


10
Anne Marinier, Alain Martel: Malonate derivatives of glycolipids as cell adhesion inhibitors. Bristol Myers Squibb Company, Aldo A Algieri, May 5, 1998: US05747463 (20 worldwide citation)

There is provided a novel series of malonate derivatives of glycolipid compounds of the formula ##STR1## wherein R is an acyl residue of a fatty acid:



Click the thumbnails below to visualize the patent trend.